John Gebhard Email & Phone Number

Director, Office of Intellectual Property and Commercialization @ University of Mississippi Medical Center

View John's Email & Phone Number

5 free lookup(s). No credit card required.

If you need more lookups, subscriptions start at $34 USD/month.

John Gebhard Location

Jackson, MS, US

John Gebhard Work

2026 -now Director, Office of Intellectual Property and Commercialization @
2025 -now Principal, Life Sciences Innovation and Partnerships @ JRG Translational Strategy
2025 -2025 Director, Technology Development and Interim Director of Licensing and Transactions @
2017 -2023 Assistant Vice President, Technology Commercialization @
2016 -2023 Executive Director, Innovation and Industry Ventures @
2014 -2017 Senior Executive Director, Innovation and Industry Ventures @
2012 -2014 Business and Technology Development @
2011 -2012 Senior Director and Consultant, Cube Linked Medicine @ Cube Linked
2008 -2011 Strategic Program Director @
2004 -2009 Vice President @ Inflabloc Pharmaceuticals
2001 -2004 Director of Research and Development @ Inflabloc Pharamceuticals
1996 -2000 Senior Scientist, Molecular Medicine @ Pharmadigm Inc.
1994 -1996 Post-Doctoral Fellow @

John Gebhard Education

University of Utah
Ph.D. (Cell, Viral and Molecular Biology)
California State University, Fullerton
M.S. (Oncology and Immunology)
Santa Clara University
B.S. (Biology)
The Scripps Research Institute
Post-Doctoral Fellowship (2 years); Mentor: J. Lindsay Whitton, M.D., Ph.D. (Viral pathogenesis)

John Gebhard Skills

Clinical Development
Pharmaceutical Industry
Clinical Trials
Lifesciences
Start-ups
Biotechnology
Strategy
Oncology
Biopharmaceuticals
Commercialization
Technology Transfer
Medical Devices
Drug Discovery
Grants
Genomics
Infectious Diseases
Research
Molecular Biology
Pharmacology
Translational Medicine
Neuroscience
Cell Biology
Immunology
Diabetes
Biomarkers
Healthcare
R&D
Patents
Cancer
Vaccines
Licensing
FDA
Cell
Biochemistry
Drug Development
Cross-functional Team Leadership
Grant Writing
Data Analysis
Medicine
CRO
Competitive Intelligence
Technology Evaluation
Therapeutic Areas
Life Sciences
Business Development
New Business Development
Management
Financial Advisory
Market
Metabolomics
Chemical
Herpes
Strategist
Animal Models
Bacterial
Community
Holistic Health
Phase Ii
Macular Degeneration
Clinical Research
Regulatory Affairs
England
Serving
Accelerator
Executive Positions
Significance
Dec Alpha
Sponsorship
Symposium
Campbell
Neuropathy
RNA
Pharmaceutical Companies
Vector
Cross Functional Team Leadership
Treatment
Nih
Disease
Acid
Plays
Design
Revenue
Crohn'S
Peptides
Science
Short
Funding
Cellular Communications
Journals
General Electric
Hp Enterprise Solutions
Toxicology
Mouse
Utah
Technology Development
Key Opinion Leaders
Medical Affairs
Nanotechnology
Virtual Screening
Committees
Leadership
Lung
Cubes
PowerPoint
Publications
Public Speaking
Cultivation
Collaborative
Execution
MENA
Breast
Physicians
Foundation
System
Business Services
Virology
Inflammation
Offering
Utilization
Validation
Sage Act
Xing
Internet Protocols
Devoted
Strategies
Microsoft Office
Attainment
Drug Delivery
Medical Liaison
Hela
Microsoft Excel
Property
Nonprofits
Testing
Point Of Contact
Customer Service
Patient
Persistent
New Companies
Virtual
Extract
Synopsis
Solution
Conferences
Virus
Prosecution
Project Management
Ingenuity
American
Informatics
Amd
Pancreas
Start Up Ventures
Venture Capital
Commercial Real Estate
Investigation
4 Disciplines Of Execution
Board of Directors
Partnerships
Molecular
Pathogenesis
Mechanisms
Combination
Raising
Broad Based
Business Partnering
R
Drug Design
Intellectual
Storing
Trials
C
Immunization
Proteomics
Inflammatory Bowel Disease
FIX Protocol
Kidney
Applications
Communication
Negotiation
DNA
Evidence
Scientific
Conversation
Operations
Author
Posters
Ophthalmology
Out Licensing
Term Sheets
Peer Reviews
Lake Homes
Austria
Diabetic Neuropathy
Drafting
Business Intelligence
Pipelines
Distribution Center Operations
Contractual Agreements
Cao
ISIS
Intellectual Property
Indications
Ctl
Franklin Covey
Presentations
Recognitions
Utility
Spain
Responsibility
Therapists
Targeted Advertising
High Throughput Screening
International
Data Warehousing
SALT
Intelligence
Biology
Google Groups
Presenter
Portfolio
Incubation
Optimistic
Start Ups
Draper
Milestone
Expression
Diabetic Retinopathy
New York
Government
Prevention
Treating
Academic
Arch
IBC
Software
Product Design
Span
Valid
Phase
Microsoft Word
Pharmaceutics
Bioinformatics
Antiviral
Versatile
Budgets
Colon
Due Diligence
Infection
Conceptual Modeling
Interventions
Strategic Alliances
Mortality
Delivery
Diabetic
Recruiting
Evaluation
Oracle ASM

John Gebhard Summary

John Gebhard, based in Jackson, MS, US, is currently a Director, Office of Intellectual Property and Commercialization at University of Mississippi Medical Center. John Gebhard brings experience from previous roles at JRG Translational Strategy, IU Innovation and Commercialization Office and UT Health San Antonio. John Gebhard holds a Ph.D. in Cell, Viral and Molecular Biology @ University of Utah. With a robust skill set that includes Clinical Development, Pharmaceutical Industry, Clinical Trials, Lifesciences, Start-ups and more. John Gebhard has 2 emails and 5 mobile phone numbers on RocketReach.